Concepedia

Ariane Wohlfarth

AW

Statistics

Publications

43

Citations

2.2K

H-Index

31

Active since

2009

Affiliations

National Institute on Drug Abuse(Current)

National Institutes of Health

Swedish National Board of Forensic Medicine

Linköping University

University Medical Center Freiburg

Ariane Wohlfarth is an author at National Institute on Drug Abuse specializing in pharmacology, drug metabolism, and mass spectrometric analysis.

ORCID

Publications per year

2009–2019

43

Publications

43

LC-MS/MS screening method for designer amphetamines, tryptamines, and piperazines in serum

Ariane Wohlfarth, Wolfgang Weinmann, Sebastian Dresen · Analytical and Bioanalytical Chemistry · 2010 · 128 citations · Full text

, , +13

Qualitative Confirmation of 9 Synthetic Cannabinoids and 20 Metabolites in Human Urine Using LC–MS/MS and Library Search

Ariane Wohlfarth, Karl B. Scheidweiler, Huafen Liu et al. · Analytical Chemistry · 2013 · 123 citations

, , +15

Metabolism of synthetic cannabinoids PB-22 and its 5-fluoro analog, 5F-PB-22, by human hepatocyte incubation and high-resolution mass spectrometry

Ariane Wohlfarth, Adarsh Gandhi, Shaokun Pang et al. · Analytical and Bioanalytical Chemistry · 2014 · 105 citations

, , +13

Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACA

Ariane Wohlfarth, Marisol S. Castaneto, Mingshe Zhu et al. · The AAPS Journal · 2015 · 104 citations · Full text

, , +8

In Vitro and In Vivo Metabolite Identification Studies for the New Synthetic Opioids Acetylfentanyl, Acrylfentanyl, Furanylfentanyl, and 4-Fluoro-Isobutyrylfentanyl

Shimpei Watanabe, Svante Vikingsson, Markus Roman et al. · The AAPS Journal · 2017 · 92 citations · Full text

, , +13

1–5 of 43